Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Find Roth IRA index funds with the lowest fees to keep more of your returns. Compare expense ratios and pick a cost-efficient fund for long-term growth.
27,085 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Barclays has boosted its Ionis target to $106, signaling a roughly 46% upside from recent levels as olezarsen eyes pe...
Bank of America upgrades FedEx to its US 1 List, signaling confidence in the company’s DRIVE plan and a stabilizing l...
Two AI models clash on XRP's path to $3 by Q4 as regulatory, liquidity, and macro factors shape divergent bets from t...
A new tech challenger aims to blend space, AI, and hardware into one powerful growth engine. This article breaks down...
Microsoft is pursuing a unifying Copilot hub to combine its AI tools into one experience, with a late-summer 2026 rol...
Cardano’s ADA dropped sharply, slipping below $0.20 as risk-off sentiment gripped crypto markets. A high-profile upda...
When a top executive sells a chunk of stock, it draws attention. This guide examines brian chesky just sold, what ins...
Two essential infrastructure players—GE Vernova and Vertiv—sit behind the scenes of AI and modern tech. This guide ex...
When a public tribute shines a light on mentors and fathers, it offers more than sentiment—it's a blueprint for famil...
OpenAI's planned IPO faces a timing change that could redefine AI stock bets. The shift underscores a tougher funding...
A sharp 34% June rally in Sandisk highlights a changing memory market. Explore the forces behind the move, what it me...